Medical Isotope Production

• Lee, Beyer, & Lee (2016). Development of Industrial-Scale Fission Mo-99 Production Process Using Low Enriched Uranium Target. Nuclear Engineering and Technology, 48(3), 613-623. https://doi.org/10.1016/j.net.2016.04.006
• OECD (2018). The Supply of Medical Radioisotopes: 2018 Medical Isotope Demand and Capacity Projection for the 2018-2023 Period. Report #NEA/SEN/HLGMR(2018)3, Nuclear Technology Development and Economics, Nuclear Energy Agency. https://www.oecd-nea.org/med-radio/docs/sen-hlgmr2018-3.pdf
• Saey (2009). The influence of radiopharmaceutical isotope production on the global radioxenon background. Journal of Environmental Radioactivity, 100(5), 396-406. https://doi.org/10.1016/j.jenvrad.2009.01.004
• Saey, Auer, Becker, Hoffmann, Nikkinen, Ringbom, et al. (2010). The influence on the radioxenon background during the temporary suspension of operations of three major medical isotope production facilities in the Northern Hemisphere and during the start-up of another facility in the Southern Hemisphere. Journal of Environmental Radioactivity, 101(9), 730-738. https://doi.org/10.1016/j.jenvrad.2010.04.016
• Saey, Bowyer, & Ringbom (2010). Isotopic noble gas signatures released from medical isotope production facilities-Simulations and measurements. Applied Radiation and Isotopes, 68(9), 1846-1854. https://doi.org/10.1016/j.apradiso.2010.04.014
• Tataurov, A.L. and O.S. Feinberg, Molten Salt Reactor for 99Mo Production. Atomic Energy, 2017. 122(5): p. 299-303. https://doi.org/10.1007/s10512-017-0270-8